The limitations of currently used clinical phototherapeutic agent, Photofrin, have prompted a search for more ideal photodynamic sensitizer. The hypocrellins, have been paid the
基金Beijing talents training project 20081D0501500180)
文摘The limitations of currently used clinical phototherapeutic agent, Photofrin, have prompted a search for more ideal photodynamic sensitizer. The hypocrellins, have been paid the
